The authors summarize the effects of fibroblast growth factors (FGFs) in fibroblast to myofibroblast differentiation and ECM protein expression and discuss the underlying potential regulatory mechanisms to provide a basis for the clinical application of recombinant FGF protein drugs in treatment of tissue damage.
[Open Biology]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News